Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.

Tölli MA, Ferreira MP, Kinnunen SM, Rysä J, Mäkilä EM, Szabó Z, Serpi RE, Ohukainen PJ, Välimäki MJ, Correia AM, Salonen JJ, Hirvonen JT, Ruskoaho HJ, Santos HA.

Biomaterials. 2014 Sep;35(29):8394-405. doi: 10.1016/j.biomaterials.2014.05.078. Epub 2014 Jun 28.

PMID:
24985734
2.

Development of porous silicon nanocarriers for parenteral peptide delivery.

Kovalainen M, Mönkäre J, Kaasalainen M, Riikonen J, Lehto VP, Salonen J, Herzig KH, Järvinen K.

Mol Pharm. 2013 Jan 7;10(1):353-9. doi: 10.1021/mp300494p. Epub 2012 Dec 7.

PMID:
23186283
3.

Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.

Bimbo LM, Sarparanta M, Santos HA, Airaksinen AJ, Mäkilä E, Laaksonen T, Peltonen L, Lehto VP, Hirvonen J, Salonen J.

ACS Nano. 2010 Jun 22;4(6):3023-32. doi: 10.1021/nn901657w.

PMID:
20509673
4.

Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.

Limnell T, Riikonen J, Salonen J, Kaukonen AM, Laitinen L, Hirvonen J, Lehto VP.

Int J Pharm. 2007 Oct 1;343(1-2):141-7. Epub 2007 May 16.

PMID:
17600644
5.

Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Kovalainen M, Mönkäre J, Mäkilä E, Salonen J, Lehto VP, Herzig KH, Järvinen K.

Pharm Res. 2012 Mar;29(3):837-46. doi: 10.1007/s11095-011-0611-6. Epub 2011 Oct 27.

PMID:
22033881
6.

In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.

Mori M, Almeida PV, Cola M, Anselmi G, Mäkilä E, Correia A, Salonen J, Hirvonen J, Caramella C, Santos HA.

Eur J Pharm Biopharm. 2014 Nov;88(3):635-42. doi: 10.1016/j.ejpb.2014.09.010. Epub 2014 Oct 8.

PMID:
25305585
7.

Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms.

Shahbazi MA, Fernández TD, Mäkilä EM, Le Guével X, Mayorga C, Kaasalainen MH, Salonen JJ, Hirvonen JT, Santos HA.

Biomaterials. 2014 Nov;35(33):9224-35. doi: 10.1016/j.biomaterials.2014.07.050. Epub 2014 Aug 12.

PMID:
25123922
8.

¹⁸F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography.

Sarparanta M, Mäkilä E, Heikkilä T, Salonen J, Kukk E, Lehto VP, Santos HA, Hirvonen J, Airaksinen AJ.

Mol Pharm. 2011 Oct 3;8(5):1799-806. doi: 10.1021/mp2001654. Epub 2011 Sep 7.

PMID:
21875120
9.

Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

Huotari A, Xu W, Mönkäre J, Kovalainen M, Herzig KH, Lehto VP, Järvinen K.

Int J Pharm. 2013 Sep 15;454(1):67-73. doi: 10.1016/j.ijpharm.2013.06.063. Epub 2013 Jul 5.

PMID:
23834832
10.

A novel pressed porous silicon-polycaprolactone composite as a dual-purpose implant for the delivery of cells and drugs to the eye.

Irani YD, Tian Y, Wang M, Klebe S, McInnes SJ, Voelcker NH, Coffer JL, Williams KA.

Exp Eye Res. 2015 Oct;139:123-31. doi: 10.1016/j.exer.2015.08.007. Epub 2015 Aug 12.

PMID:
26277579
11.

Cellular interactions of surface modified nanoporous silicon particles.

Bimbo LM, Sarparanta M, Mäkilä E, Laaksonen T, Laaksonen P, Salonen J, Linder MB, Hirvonen J, Airaksinen AJ, Santos HA.

Nanoscale. 2012 May 21;4(10):3184-92. doi: 10.1039/c2nr30397c. Epub 2012 Apr 16.

PMID:
22508528
12.

The amelioration of cardiac dysfunction after myocardial infarction by the injection of keratin biomaterials derived from human hair.

Shen D, Wang X, Zhang L, Zhao X, Li J, Cheng K, Zhang J.

Biomaterials. 2011 Dec;32(35):9290-9. doi: 10.1016/j.biomaterials.2011.08.057. Epub 2011 Sep 1.

PMID:
21885119
13.

Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery.

Liu D, Herranz-Blanco B, Mäkilä E, Arriaga LR, Mirza S, Weitz DA, Sandler N, Salonen J, Hirvonen J, Santos HA.

ACS Appl Mater Interfaces. 2013 Nov 27;5(22):12127-34. doi: 10.1021/am403999q. Epub 2013 Nov 13.

PMID:
24175755
14.

Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.

Shrestha N, Shahbazi MA, Araújo F, Zhang H, Mäkilä EM, Kauppila J, Sarmento B, Salonen JJ, Hirvonen JT, Santos HA.

Biomaterials. 2014 Aug;35(25):7172-9. doi: 10.1016/j.biomaterials.2014.04.104. Epub 2014 May 17.

PMID:
24844163
15.

Functionalization of alkyne-terminated thermally hydrocarbonized porous silicon nanoparticles with targeting peptides and antifouling polymers: effect on the human plasma protein adsorption.

Wang CF, Mäkilä EM, Bonduelle C, Rytkönen J, Raula J, Almeida S, Närvänen A, Salonen JJ, Lecommandoux S, Hirvonen JT, Santos HA.

ACS Appl Mater Interfaces. 2015 Jan 28;7(3):2006-15. doi: 10.1021/am507827n. Epub 2015 Jan 13.

PMID:
25539741
16.

Multifunctional porous silicon for therapeutic drug delivery and imaging.

Santos HA, Bimbo LM, Lehto VP, Airaksinen AJ, Salonen J, Hirvonen J.

Curr Drug Discov Technol. 2011 Sep;8(3):228-49. Review.

PMID:
21291407
17.

Recent advances in porous silicon technology for drug delivery.

Barnes TJ, Jarvis KL, Prestidge CA.

Ther Deliv. 2013 Jul;4(7):811-23. doi: 10.4155/tde.13.52. Review.

PMID:
23883125
18.

Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.

Kilpeläinen M, Mönkäre J, Vlasova MA, Riikonen J, Lehto VP, Salonen J, Järvinen K, Herzig KH.

Eur J Pharm Biopharm. 2011 Jan;77(1):20-5. doi: 10.1016/j.ejpb.2010.10.004. Epub 2010 Oct 20.

PMID:
20965250
19.

Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.

Tang F, Li L, Chen D.

Adv Mater. 2012 Mar 22;24(12):1504-34. doi: 10.1002/adma.201104763. Epub 2012 Feb 29. Review.

PMID:
22378538
20.

Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis.

Ladage D, Yaniz-Galende E, Rapti K, Ishikawa K, Tilemann L, Shapiro S, Takewa Y, Muller-Ehmsen J, Schwarz M, Garcia MJ, Sanz J, Hajjar RJ, Kawase Y.

PLoS One. 2013 May 20;8(5):e59656. doi: 10.1371/journal.pone.0059656. Print 2013.

Supplemental Content

Support Center